Washington Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Washington Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,200	Closed	-$333K	–	104
2023 Q2	$333K	Hold	5,200	–	–	0.28%	96
2023 Q1	$360K	Hold	5,200	–	–	0.32%	90
2022 Q4	$374K	Hold	5,200	–	–	0.34%	86
2022 Q3	$370K	Sell	5,200 -22,920	-82%	-$1.66M	0.37%	90
2022 Q2	$2.17M	Sell	28,120 -440	-2%	-$33.5K	2.08%	5
2022 Q1	$2.09M	Hold	28,560	–	–	1.72%	5
2021 Q4	$1.78M	Sell	28,560 -515	-2%	-$30.2K	1.44%	10
2021 Q3	$1.72M	Buy	29,075 +4,325	+17%	+$285K	1.52%	9
2021 Q2	$1.65M	Buy	24,750 +140	+0.6%	+$9.13K	2%	9
2021 Q1	$1.55M	Buy	24,610 +165	+0.7%	+$10.3K	1.44%	10
2020 Q4	$1.52M	Sell	24,445 -20	-0.1%	-$1.23K	1.45%	12
2020 Q3	$1.48M	Hold	24,465	–	–	1.51%	15
2020 Q2	$1.44M	Sell	24,465 -4,940	-17%	-$295K	1.6%	13
2020 Q1	$1.64M	Sell	29,405 -10,995	-27%	-$672K	2.06%	9
2019 Q4	$2.59M	Sell	40,400 -1,635	-4%	-$93.6K	2.23%	7
2019 Q3	$2.13M	Buy	42,035 +2,015	+5%	+$94.7K	2.09%	12
2019 Q2	$1.81M	Buy	40,020 +830	+2%	+$38.7K	2.06%	16
2019 Q1	$1.87M	Sell	39,190 -2,800	-7%	-$139K	2.12%	12
2018 Q4	$2.18M	Buy	41,990 +1,700	+4%	+$91.3K	2.53%	9
2018 Q3	$2.5M	Sell	40,290 -800	-2%	-$47.5K	2.4%	9
2018 Q2	$2.27M	Hold	41,090	–	–	2.34%	12
2018 Q1	$2.6M	Hold	41,090	–	–	2.61%	11
2017 Q4	$2.52M	Hold	41,090	–	–	2.52%	12
2017 Q3	$2.62M	Hold	41,090	–	–	2.78%	8
2017 Q2	$2.29M	Hold	41,090	–	–	2.58%	11
2017 Q1	$2.23M	Hold	41,090	–	–	2.59%	12
2016 Q4	$2.4M	Buy	+41,090	New	+$2.25M	2.96%	8

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Washington Capital Management's BMY Position: Q3 2023 in Review

Washington Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 5,200 shares — an estimated $333K sold.

Washington Capital Management first reported a position in BMY in Q4 2016 and held it in 27 quarters. The position peaked at $2.62M in Q3 2017. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Washington Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Washington Capital Management sold 5,200 Bristol-Myers Squibb shares in Q3 2023, an estimated $333K.
Washington Capital Management first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 27 quarters.
Washington Capital Management's Bristol-Myers Squibb position peaked at $2.62M in Q3 2017.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Washington Capital Management's 13F filing for Q3 2023, filed 26 Oct 2023.